Dental robotics leader Neocis secures $20M in funding

Despite challenging macroeconomic conditions, Neocis secured $20M in financing in 2023 to accelerate growth, with funding participation from Mirae Asset Financial Group and NVIDIA.

MIAMI, Jan. 10, 2024 — Neocis®, the global leader in robot-assisted dental implant surgery, announced today that the company has raised $20M in additional funding. This latest round of financing included Mirae Asset Capital/Mirae Asset Venture Investment, venture capital firms affiliated with the Mirae Asset Financial Group that invest in growth-stage healthcare and technology businesses, and NVentures, NVIDIA’s venture capital arm.

 

Headquartered in Miami, Neocis manufactures and markets Yomi®, dentistry’s first and only robotic surgical system cleared by the U.S. Food and Drug Administration (FDA). The Yomi platform, which has received a total of 16 FDA 510(k) clearances, assists clinicians during all phases of implant placement via streamlined digital planning and haptic guidance of surgical instrumentation, so users can deliver precise and efficient treatment. To date, more than 40,000 implants have been placed with robotic assistance. A dental implant is placed with Yomi approximately every six minutes, according to current data from Neocis.

 

“The latest investment is a testament to our growth as a company and how far dental robotics has come since the first Yomi systems were installed,” said Alon Mozes, Neocis’ co-founder and CEO. “We’re tremendously grateful to have the backing of our newest investors, including NVentures and Mirae Asset Financial Group, as well as our existing partners. This funding positions us for continued success in the market and will help us drive meaningful innovation in implant dentistry.”

 

Neocis, which was named one of South Florida’s 50 fastest growing companies last year by the South Florida Business Journal, will use these additional funds to bolster a wide range of business initiatives from product development and sales enablement to clinical education. To keep pace with the company’s steady growth, Neocis moved into a larger space last summer. The new headquarters, which houses a state-of-the-art manufacturing facility, is located in Miami’s bustling Wynwood neighborhood.

 

“Neocis is bringing needed innovation to dentistry, and we couldn’t be more excited to support them in that mission,” said Mirae Asset Capital’s Investment Manager, Soojung Kim. “We look forward to working alongside the Neocis team to help them excel in a rapidly growing market and get Yomi in the hands of more providers.”

 

“Robotics and AI are changing the face of dentistry, enabling innovations that increase doctor efficiency and help them improve the quality of life for their patients,” said Mohamed “Sid” Siddeek, corporate vice president and head of NVentures. “Neocis is transforming dental implant procedures, demonstrating the benefits of robotics and AI in healthcare.”

 

To learn more about Neocis and the Yomi platform, visit neocis.com.

 

About Yomi
Yomi is a computerized robotic navigational system intended to provide assistance in both the planning and intraoperative phases of dental implant surgery. The platform can also be used to plan and execute robot-guided alveoloplasty. Yomi is intended for use in partially edentulous and fully edentulous adult patients who qualify for dental implants. Visit neocis.com to learn more about Yomi or schedule a hands-on demo.

 

About Neocis
Neocis is transforming dental surgery with robotics. The company collaborates closely with leading clinicians across all dental specialties to develop innovative technologies that help advance patient care and improve quality of life. Based in Miami, Neocis is venture-backed with funding from NVentures, Mirae Asset Financial Group, Intuitive Ventures, DFJ Growth, Mithril Capital Management, Norwest Venture Partners, Vivo Capital, Section 32, and surgical robotics pioneer Fred Moll. For more information, visit neocis.com.

 

Contact
For more information, please contact the Neocis media relations team at info@neocis.com.

Yomi Robotic Platform’s New Bone Reduction Feature Launches Commercially

Latest indication allows clinicians to leverage the accuracy, precision, and intraoperative flexibility of robotic assistance when performing alveoloplasty – a key phase of many full-arch cases

MIAMI, April 12, 2023 — Neocis®, manufacturer of Yomi® and the global leader in robot-assisted dental surgery, announced today the official market launch of the platform’s bone reduction module. Cleared by the U.S. Food and Drug Administration (FDA) in November of 2022, this latest offering from Neocis enables dental professionals to use Yomi to precisely plan bone reduction (using a patient’s CT scan) and then execute the treatment plan with the help of robotic guidance.

 

Yomi, the first and only FDA-cleared robotic system for dental surgery, assists clinicians in planning and operative phases of dental implant placement via interactive digital planning (using YomiPlan™ software) and haptic guidance of surgical instrumentation. The Yomi platform, which received a prized Cellerant Best of Class Technology Award last summer, has helped general dentists and specialists place more than 28,000 implants and perform upwards of 16,000 robot-guided cases. Every ten minutes a dental implant is placed robotically, according to current data from Neocis.

 

Alveoloplasty is a common dental procedure during which the surface of a patient’s alveolar bone is reshaped and reduced to prepare a foundation for a full-arch restoration. Achieving a smooth, level ridge with enough room for a prosthesis contributes to predictable, long-lasting outcomes. Yomi’s bone reduction module, Neocis’ 14th FDA clearance, is designed to help clinical teams throughout the planning and intraoperative phases of this procedure, so they can perform complex full-arch cases with confidence and efficiency.

 

“I’ve been doing full-mouth reconstruction for a long time, and I can say that Yomi takes bone reduction to the next level,” said Dr. Sanju Jose, a periodontist in the Baltimore-Washington metropolitan area and one of the first clinicians in the country to use this new feature in a live surgical setting. “After just a few cases, I knew this functionality would be a game-changer for us. Every time my team uses Yomi for ridge reduction, we look at each other and say, ‘this is amazing.’”

 

Robot-guided alveoloplasty is a novel approach that avoids some of the drawbacks associated with traditional surgical methods. Yomi physically prevents the user from moving the cutting bur beyond the precise reduction boundaries defined in the treatment plan and provides a clear virtual reference of how much bone has been removed. Unlike physical guides, robotic assistance enables intraoperative treatment modifications, allows for unobstructed visualization, irrigation, and palpation of the surgical site, and doesn’t require the clinician to reflect large flaps, which helps maintain blood supply to the bone.

 

“Yomi saves me a bunch of time by allowing me to precisely plan every dimension of the reduction volume for each patient,” said Dr. Scott Clayhold, an oral and maxillofacial surgeon in the Seattle area. “Then, I have the clinical flexibility to take the bur where I want, knowing that Yomi will prevent me from going beyond the boundaries I’ve set in my plan. That’s the beauty of robot-guided surgery.”

 

To learn more about the Yomi system and this new clinical offering, visit neocis.com/bone-reduction.

 

About Yomi
The Yomi robotic system is a computerized robotic navigational system intended to provide assistance in both the planning (preoperative) and the surgical (intraoperative) phases of dental implantation surgery. The system provides software to preoperatively plan dental implantation procedures and provides robotic navigational guidance of the surgical instruments. The system can also be used for planning and performing guided bone reduction (also known as alveoloplasty) of the mandible and/or maxilla. Yomi is intended for use in partially edentulous and fully edentulous adult patients who qualify for dental implants.

 

Since 2016, Yomi has been helping clinicians around the country plan and place dental implants with a high level of precision and efficiency, so they can operate with confidence, expand their practices, and deliver an excellent patient experience. The platform has assisted in the placement of more than 28,000 implants. Visit neocis.com to learn more about Yomi or schedule a hands-on demo.

 

About Neocis
Neocis is transforming dental surgery with robotics. The company collaborates closely with leading clinicians to develop innovative technologies that help advance patient care and improve quality of life. Based in Miami, Neocis is venture-backed with funding from Intuitive Ventures, DFJ Growth, Mithril Capital Management, Norwest Venture Partners, Vivo Capital, Section 32, and surgical robotics pioneer Fred Moll. For more information, visit neocis.com.

 

Contact
For more information, please contact the Neocis media relations team at info@neocis.com.